Companies / Florida / TuHURA Biosciences

· rebuilt nightly from public records

Signal Sheet

Selling to TuHURA Biosciences? Who to reach and why now

TuHURA Biosciences is a publicly listed pharmaceutical preparations company in Tampa, Florida. It raised $1.5M in Oct 2025 and its filings name 7 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Florida

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerJames BiancoSEC filing, Oct 2025Named officer in the filing; part of the buying group
Executive OfficerDan DearbornSEC filing, Oct 2025Named officer in the filing; part of the buying group
Chief Technology OfficerJames ManusoSEC filing, Oct 2025Technology and tooling decisions
Chief Technology OfficerGeorge NgSEC filing, Oct 2025Technology and tooling decisions
Chief Technology OfficerAlan ListSEC filing, Oct 2025Technology and tooling decisions
Chief Technology OfficerRobert HoffmanSEC filing, Oct 2025Technology and tooling decisions
Chief Technology OfficerCraig TendlerSEC filing, Oct 2025Technology and tooling decisions
For sellersWhy TuHURA Biosciences is worth a call this quarterBuy Window: open · new leadership Sep 2026
Sep 10Sep 2026

New leadership

TuHURA Biosciences, Inc./NV: Officer or director change

New leadership
$1.5M

Raised

Equity raise reported to the SEC, Oct 2025. Money arrives before the spending plan does.

Capital
$3.7M4 months

Back-to-back raises

2 equity raises in 4 months. Repeat funding is a company buying for growth, not maintenance.

Pattern
Track TuHURA Biosciences with a free trial →Get the next signal the day it is filed or posted.
Email me the next TuHURA Biosciences signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Sep 10, 2026TuHURA Biosciences, Inc./NV: Officer or director changeNew leadershipSEC filing
Sep 10, 2026TuHURA Biosciences, Inc./NV: Officer or director changeNew leadershipSEC filing
Oct 27, 2025Raised $1.5M in equity from 1 investorsCapitalSEC filing
Jun 2, 2025Raised $2.2M in equity from 36 investorsCapitalSEC filing

Email format

TuHURA Biosciences uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern. A company pattern is the common shape, not a guarantee for any one person. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. So Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, and a free trial gives you the email that reaches each person above.
Get verified addresses, free →

Reach TuHURA Biosciences with emails that land

Lakewave finds the right people at TuHURA Biosciences, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on TuHURA Biosciences with a free trial →

About TuHURA Biosciences

HeadquartersTampa, Florida, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$2.2M (Jun 2025) · $1.5M (Oct 2025)

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Longeveron · 22Silo Pharma · 18Akari Therapeutics · 18Cadrenal Therapeutics · 8Jupiter Neurosciences · 4See all 5 with a free trial →

Questions people ask

Did TuHURA Biosciences raise funding in 2025?

Yes. TuHURA Biosciences reported a $1.5M equity raise to the SEC on Oct 27, 2025 with 1 investors.

Who runs TuHURA Biosciences?

The company's SEC filing, Oct 2025 names James Bianco (Executive Officer) among its officers.

Where is TuHURA Biosciences headquartered?

Tampa, Florida, per the address on its SEC filing.

What is TuHURA Biosciences's email format?

TuHURA Biosciences uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern.

Does everyone at TuHURA Biosciences use the same email format?

Not always. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. That is why Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, so you are not relying on a guessed pattern.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.